Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G/A Coherus Oncology, Inc. Filed by: SATTERFIELD THOMAS A JR

April 29, 2026 9:03 PM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: * Based on 149,889,902 shares of common stock of the issuer outstanding as of February 28, 2026, as reported by the issuer on its Annual Report on Form 10-K for the year ended December 31, 2025.


SCHEDULE 13G



Thomas A. Satterfield, Jr.
Signature:/s/ Thomas A. Satterfield, Jr.
Name/Title:Thomas A. Satterfield, Jr.
Date:04/29/2026

Categories

SEC Filings